Associate Safety Director

Über den Job

Associate Safety Director (m/f/d) (LSW)- Drug safety/pharmacovigilance/ English

Background: Portfolio Safety Scientists (PCS-Sci) provide safety science and pharmacovigilance support to

molecules across the Roche portfolio. As a group, they are responsible for all aspects of safety

science/pharmacovigilance, with accountability being held by PCS leadership and experts or SSLs (Safety

Strategy Program Leaders) depending on the deliverable/activity. The Portfolio Safety Scientists (PCS-Sci)

supports early and late phase development activities as a member of the safety team, providing essential

safety oversight and input into all aspects of study management across the entire development and marketed

portfolio. In the post-market setting this may include signal evaluation, safety related activities associated with

new drug applications/regulatory filings, benefit-risk assessment and safety risk management. The Associate

Safety Director will be expected to work with minimal supervision and apply strong self-leadership. The job

holder will be expected to complete the required training.

The Perfect Candidate: The perfect candidate is an Associate Safety Director with at least 4 years of drug

development experience, including a minimum of 3 years in drug safety/pharmacovigilance, and is a qualified

healthcare or life sciences professional. This individual must possess the expert understanding required to

proactively manage all aspects of product safety, including signal detection, risk

management (RMP/CCDS), and complex data analysis, while ensuring all documentation and regulatory

submissions adhere to GxP standards.

Tasks & Responsibilities:

Develop and maintain an understanding of the safety profile of their assigned product(s) or therapy areas.

Develop and maintain an expert understanding of the safety profile of the assigned product(s) as well as

understanding of the relevant strategic context (e.g., disease under study, safety profile of competitors,

mechanism of action).

• Responsible for individual and aggregate case reporting activities including ICSR case management

(medical review) and aggregate reporting (i.e. DSUR, PBRER).

• Responsible for signal detection and management activities. Contribute to the strategy and review of

safety assessments and drug safety reports for signals or issues (incl, product quality) or in response to

Regulatory Authority requests.

• Provide expert contribution to the development of the product safety strategy.
• Take independent responsibility for risk management activities including preparation and maintenance

of CCDS, labeling document maintenance (including IB), risk communications, RMP.

• Review of clinical protocols, study reports, Investigator's Brochure (IB), informed consent form (ICF)

and other related documents to ensure alignment with the safety strategy and ensure the

appropriateness of risk management strategies and risk communication.

• Take responsibility for safety science contributions to regulatory authority submissions (Investigational

New Drug/IND applications, New Drug Applications/NDAs, Marketing Authorization

Applications/MAAs, Variations, Renewals, etc.).

• Responsible for the preparation and maintenance of safety sections of the Company Core Data Sheet

and/or Reference Safety Information in the IB. • Participate in and provide input for Drug Monitoring Committees (iDMC) or internal monitoring

committee (IMC) meetings, as applicable.

• In partnership with the SSL, support presentation of important safety issues to the Drug Safety

Committee (DSC), Development Review. Committee (DRC) and other internal and external review and

governance committees as needed.

• Acts independently to manage safety responsibilities on study teams and in activities supporting

clinical safety.

• Take on the responsibility for specialised roles with PCS. These may include, but are not limited to;

functional business process owner, subject matter expert. May be expected to support non-molecule

projects, due diligence evaluations and other projects as needed.

• Perform specialized roles with PCS. These may include, but are not limited to; functional business

process owner, subject matter expert, safety committee member.

• Responsible for coordination and collaboration with vendors servicing Safety Science. Understanding

of GxP and regulated processes and end to end clinical trial lifecycle

Must Haves :

• Qualified healthcare professional or Life Sciences graduate. Preferred Qualifications: A relevant

postgraduate qualification (e.g. PHD/MSc in a Life sciences discipline; PharmD or other post-graduate

health professional qualifications) would be advantageous.

• Work Experience 4 or more years of drug development experience in the pharmaceutical or related

industry.

• At least 3 years in drug safety/PV or a closely related field
• Minimum level required Associate Safety Director
• IT/Tool Skills good excel/word/powerpoint skills; able to extract data from the Safety Database and

apply complex data analysis

• Language Skills: Fluent in English, both written and verbal

Reference Nr.: 925025

Role: Associate Safety Director

Industrie: Pharma

Workplace: Basel

Pensum: 100%

Start: 21.08.2026

Duration: 12 months ++

Deadline :24.06.2026

If you are interested in this position, please send us your complete dossier. If this position does not fit your

profile and you wish to be considered for another position directly, you can also send us your dossier via this

ad or to jobs[at]itcag[dot]com.

Contact us for more information about our company, our positions or our attractive Payroll-Only programme:

+41 41 760 77 01.

About us: ITech Consult is an ISO 9001:2015 certified Swiss company with offices in Germany and Ireland.

ITech Consult specialises in the placement of highly qualified candidates for recruitment in the fields of IT, Life

Science & Engineering.We offer staff leasing & payroll services. For our candidates this is free of charge, also for Payroll we do not

charge you any additional fees.